美军特需药品军民融合管理经验借鉴研究  

Experience from the U.S. military and civilian integration management of drugs for military special needs

作　　者：高雪[1] 高云华[2] 林仲武[1] 

机构地区：[1]军事医学科学院科技部科研项目处,北京100850 [2]军事医学科学院卫生勤务与医学情报研究所,北京100850

出　　处：《军事医学》2017年第4期299-302,共4页Military Medical Sciences

摘　　要：军队特需药品(简称"军特药")是军队保障作战需要和维护国家安全的重要战略物资,历来受到各国军队高度重视。美军在长期的军特药管理中,取得了许多宝贵的经验与教训。该文通过整合分析美军与FDA的军特药在科研、采购、使用和储备等方面的军民融合管理现状,系统总结其成功经验,发现存在问题,并对我军探索适合自身特色的军特药军民融合管理提出系列建议。Drugs for military special needs are important strategic materials for supporting military operational needs and maintaining national security,and are highly valued by Armed Forces in each country in the world.The U.S.military has accumulated much experience through the long-term management of drugs for military special needs.Here,The U.S.military and civilian integration management of drugs for military special needs between the U.S.DOD and FDA was analyzed in terms of research,purchase,use and storage,the secrets of success were summarized,and problems were identified.Finally,recommendations on military and civilian integration management of drugs for military special needs in China were proposed.

关 键 词：军队特需药 军民融合 经验借鉴 

分 类 号：R82[医药卫生—临床医学]